Hikma Pharmaceuticals Plc Director/PDMR Shareholding (2004T)
18 Marzo 2019 - 4:09PM
UK Regulatory
TIDMHIK
RNS Number : 2004T
Hikma Pharmaceuticals Plc
18 March 2019
Hikma Pharmaceuticals PLC - EIP Awards
LONDON, 18 March 2019: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards on 17 March 2016 under the 2014 Executive
Incentive Plan ("EIP") which was completed on 18 March 2019. These
awards were automatically exercised by operation of the conditional
award and vesting process. The exercise price under the EIP is
GBPnil.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 45,100
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 25,406
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 26,090
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 20,400
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 14,530
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 March 2019 under the 2014 EIP.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 19,890
d) Aggregated information N/A
e) Date of the transaction 18 March 2019
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBUGDXIGBBGCI
(END) Dow Jones Newswires
March 18, 2019 11:09 ET (15:09 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024
